共 33 条
Sendai viral vector mediated angiopoietin-1 gene transfer for experimental ischemic limb disease
被引:51
作者:
Huang, Jianhua
[1
,2
]
Inoue, Makoto
[3
]
Hasegawa, Mamoru
[3
]
Tomihara, Kei
[1
]
Tanaka, Toshihiro
[1
]
Chen, Jiahua
[2
]
Hamada, Hirofumi
[1
]
机构:
[1] Sapporo Med Univ, Dept Mol Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan
[2] NingXia Peoples Hosp, Dept Thorac & Cardiovasc Surg, Yinchuan 750021, Peoples R China
[3] DNAVEC Res Corp, Tsukuba, Ibaraki, Japan
关键词:
Peripheral arterial obstructive disease;
Sendai virus vector;
Angiopoietin-1;
Ischemia;
Lower limb;
Rat;
ENDOTHELIAL GROWTH-FACTOR;
VIRUS VECTORS;
AUGMENTS REVASCULARIZATION;
INTRAMUSCULAR INJECTION;
CELL-SURVIVAL;
TIE2;
RECEPTOR;
EXPRESSION;
RNA;
ANGIOGENESIS;
VEGF;
D O I:
10.1007/s10456-009-9144-6
中图分类号:
R6 [外科学];
学科分类号:
100210 [外科学];
摘要:
Sendai virus vector is emerging as a promising vector for gene therapy, and angiopoietin-1 (Ang-1) has been reported to improve the blood flow recovery in the ischemic limb or heart. In this study, we constructed a human Ang-1-expressing Sendai viral vector (SeVhAng-1) and injected it into the ischemic limb of rats. We found that SeVhAng-1 improved the blood flow recovery and increased the capillary density of the ischemic limb, compared with the controls. We also found that SeVhAng-1 increased p-Akt during the early period of limb ischemia, and decreased apoptosis in ischemic limb. It suggests that SeVhAng-1 may serve as a potential therapeutic tool in ischemic limb disease.
引用
收藏
页码:243 / 249
页数:7
相关论文

